Vanda Pharmaceuticals shares are trading higher after the FDA approved BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia, marking a significant step in psychiatric innovation.

Psyence BioMed shares are trading higher after the company announced the exercise of a put option by PsyLabs, resulting in a strategic equity investment.

Grail Inc. shares are trading lower after the company's NHS-Galleri trial failed to meet its primary clinical endpoint, resulting in a 48% decline in after-hours trading.

Rimini Street shares are trading higher after the company announced strong fiscal fourth-quarter and annual 2025 financial results, exceeding guidance and seeing solid growth in core subscription billings.

Eldorado Gold shares are trading lower after the company announced that first concentrate production at its Skouries project has been delayed, impacting capital expenditures and future cash flows.

Senti Biosciences shares are trading higher after the company participated in a Cell & Gene Live event highlighting emerging technologies in cell therapy, leveraging their proprietary Gene Circuit platform to advance innovative treatments.

Cogent Communications shares are trading lower after the company reported a 6.3% decrease in annual service revenue for 2025 compared to 2024. This decline is primarily attributed to decreases in on-net and off-net revenue, even as wavelength revenue witnessed significant growth.

CDT shares are trading higher after the company announced it has acquired a 20% equity stake in Sarborg Limited, enhancing strategic alignment and growth opportunities.

Metallus Inc. shares are trading lower after the company reported a net loss of $14.3 million for the fourth quarter of 2025, alongside rising operational costs and lower gross profits compared to the previous year.

Indie Semiconductor shares are trading higher after the company reported strong Q4 financial results, exceeding the midpoint of its outlook, and showcased significant growth in its core business and expansion into high-growth sectors like humanoid robotics.

Harmonic shares are trading higher after the company announced a strategic partnership with izzi to accelerate the expansion of fiber broadband in Mexico. This collaboration will leverage Harmonic's cOS virtualized broadband platform, simplifying fiber rollouts and reducing infrastructure costs, indicating strong future business prospects.

Tandem Diabetes Care shares are trading higher after the company reported financial results showing it surpassed $1 billion in worldwide sales for 2025, marking a significant milestone. This achievement was highlighted by a 15% increase in worldwide sales and strategic initiatives that drove operational improvements and margins.

Auddia shares are trading lower after the company announced the expiration of its publicly traded warrants, leaving the warrants completely void and without value.

Jakks Pacific shares are trading higher after the company reported improved Q4 gross margins and a significant reduction in adjusted net loss, signaling strong progress towards long-term goals.

Envirotech Vehicles shares are trading higher after Azio AI received its first ASIC purchase order and announced an expanded collaboration focused on infrastructure validation.

Workiva shares are trading higher after the company reported robust financial results for Q4 and FY 2025, highlighting a 22% increase in subscription revenue and improved profitability.

DNOW shares are trading higher after the company reported strong financial results for 2025, highlighted by a successful merger with MRC Global that expands growth opportunities and enhances strategic positioning.

RingCentral shares are trading higher after the company reported robust Q4 and full-year 2025 financial results, highlighted by record free cash flow and significant growth in AI-powered product adoption.

Inseego shares are trading lower despite reporting Q4 2025 revenue growth and improved GAAP net income, as market concerns remain over future revenue and EBITDA forecasts.

Ardelyx shares are trading lower after the company reported 2025 financial results that showed a significant net loss of $61.6 million, despite a strong revenue growth in IBSRELA, reflecting challenges in their overall financial health.